Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion - Trial NCT06211712
Access comprehensive clinical trial information for NCT06211712 through Pure Global AI's free database. This phase not specified trial is sponsored by Huashan Hospital and is currently Not yet recruiting. The study focuses on Acute Ischemic Stroke. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Huashan Hospital
Timeline & Enrollment
N/A
Jan 01, 2024
Dec 01, 2025
Primary Outcome
ASPECT score evaluated using routine CT,Modified Rankin Scale (mRS) score
Summary
The purpose of this study is to evaluate the safety and efficacy of Human Urinary
 Kallidinogenase combined with endovascular therapy in acute ischemic stroke (AIS) patients
 with large vessel occlusion.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06211712
Non-Device Trial